Skip to main content
logo
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.650
-0.040 (-2.37%)
At close: Feb 11, 2026, 4:00 PM EST
1.680
+0.030 (1.82%)
After-hours: Feb 11, 2026, 7:36 PM EST

Allogene Therapeutics Revenue

In the year 2024, Allogene Therapeutics had annual revenue of $22.00K, down -76.84%.

Revenue (ttm)
$22.00K
Revenue Growth
-76.84%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
229
Market Cap
370.80M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202422.00K-73.00K-76.84%
Dec 31, 202395.00K-61.00K-39.10%
Dec 31, 2022156.00K-113.93M-99.86%
Dec 31, 2021114.09M--
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Entrada Therapeutics61.52M
Autolus Therapeutics51.13M
Bicycle Therapeutics28.34M
Aclaris Therapeutics15.74M
Absci2.82M
Revenue Rankings

ALLO News

More News